PT  - JOURNAL ARTICLE
AU  - Christopher P Kellner
AU  - Eric Sauvageau
AU  - Kenneth V Snyder
AU  - Kyle M Fargen
AU  - Adam S Arthur
AU  - Raymond D Turner
AU  - Andrei V Alexandrov
TI  - The VITAL study and overall pooled analysis with the VIPS non-invasive stroke detection device
AID  - 10.1136/neurintsurg-2017-013690
DP  - 2018 Nov 01
TA  - Journal of NeuroInterventional Surgery
PG  - 1079--1084
VI  - 10
IP  - 11
4099  - http://jnis.bmj.com/content/10/11/1079.short
4100  - http://jnis.bmj.com/content/10/11/1079.full
SO  - J NeuroIntervent Surg2018 Nov 01; 10
AB  - Introduction Effective triage of patients with emergent large vessel occlusion (ELVO) to endovascular therapy capable centers may decrease time to treatment and improve outcome for these patients. Here we performed a derivation study to evaluate the accuracy of a portable, non-invasive, and easy to use severe stroke detector.Methods The volumetric impedance phase shift spectroscopy (VIPS) device was used to assign a bioimpedance asymmetry score to 248 subjects across three cohorts, including 41 subjects presenting as acute stroke codes at a major comprehensive stroke center (CSC), 79 healthy volunteers, and 128 patients presenting to CSCs with a wide variety of brain pathology including additional stroke codes. Diagnostic parameters were calculated for the ability of the device to discern (1) severe stroke from minor stroke and (2) severe stroke from all other subjects. Patients with intracranial hardware were excluded from the analysis.Results The VIPS device was able to differentiate severe stroke from minor strokes with a sensitivity of 93% (95% CI 83 to 98), specificity of 92% (95% CI 75 to 99), and an area under the curve (AUC) of 0.93 (95% CI 0.85 to 0.97). The device was able to differentiate severe stroke from all other subjects with a sensitivity of 93% (95% CI 83 to 98), specificity of 87% (95% CI 81 to 92), and an AUC of 0.95 (95% CI 0.89 to 0.96).Conclusion The VIPS device is a portable, non-invasive, and easy to use tool that may aid in the detection of severe stroke, including ELVO, with a sensitivity of 93% and specificity of 92% in this derivation study. This device has the potential to improve the triage of patients suffering severe stroke.